Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting

by Heba Alshaker, Heba Alshaker, Qi Wang, Daniel Brewer, Daniel Brewer, Dmitri Pchejetski
Published 2019-03-01

Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target

by Heba Alshaker, Hannah Thrower, Dmitri Pchejetski
Published 2020-03-01

A case of severe dry eye disease with corneal melting as presenting complaint of acute myeloid leukaemia

by Dmitri Pchejetski, Heba Alshaker, Radomir Babovic, Kyaw Maw
Published 2021-02-01

Bradycardia and syncope as sole manifestations of a cranial lesion: a case report

by Dmitri Pchejetski, Mojiba Kenbaz, Heba Alshaker, Kiruparajan Jesudason
Published 2020-01-01

Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer

by Qi Wang, Heba Alshaker, Torsten Böhler, Shyam Srivats, Yimin Chao, Colin Cooper, Dmitri Pchejetski
Published 2017-07-01

Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1

by Heba Alshaker, Qi Wang, Torsten Böhler, Robert Mills, Mathias Winkler, Tawfiq Arafat, Yoshiaki Kawano, Dmitri Pchejetski
Published 2017-06-01

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups

by Heba Alshaker, Robert Mills, Ewan Hunter, Matthew Salter, Aroul Ramadass, Benjamin Matthew Skinner, Willem Westra, Jayne Green, Alexandre Akoulitchev, Mathias Winkler, Dmitri Pchejetski
Published 2021-01-01